Skip to main content

Actuate Therapeutics Inc. (ACTU) Insider Trading

In the last 90 days, 1 Actuate Therapeutics Inc. (ACTU) insider reported 1 open-market purchase totaling $50,000 and no sales. The most recent open-market purchase was reported on Oct 28, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$50,000
Corporate buyers
1
Latest transaction
Oct 28, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 28, 2026Daniel M SchmittPresident, CEO and DirectorOpen Market Purchase140,844$0.36$50,000

Common questions

ACTU insider trading FAQ

Are ACTU insiders buying or selling?
Over the last 90 days, ACTU insiders were net buyers, reporting $50,000 of open-market purchases and $0.00 of sales.
When was the last ACTU insider purchase?
The most recent open-market purchase of Actuate Therapeutics Inc. stock by an insider was reported on Oct 28, 2026, one of 1 purchase in the last 90 days.
Where does ACTU insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Actuate Therapeutics Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.